September 25, 2025Open Access

Navigation of the Hemophilia Drug Choice-Paralysis: A Quick User Guide to New and Existing Therapies

View Full Paper

Ask AI

Bookmark

Authors

Discussion

Review outlines FDA-approved hemophilia therapies, highlighting new and existing options for clinicians.

Navigating the extensive hemophilia therapies can be challenging for clinicians, affecting patient care and outcomes.
The review covers FDA-approved products, including extended half-life drugs and gene therapy, improving treatment options.
Traditional treatments involved factor administration for bleeding, but new therapies offer diverse approaches for management.
Understanding this pharmacologic landscape is essential for hematologists and emergency providers treating hemophilia.

Deanna Maida (2025) studied this question.

View Full Paper

Ask AI

Bookmark